Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
NCT05968989
Infections, Influenza
Bethesda, Maryland, United States
View Trial DetailsNCT Number: NCT01839760
The objective of the study is virological assessment (e.g., proportion of prolonged viral shedding, median days to viral clearance, and viral load) in laboratory-confirmed adult influenza patients admitted to the general ward and/or to the ICU and to assess the correlation with the clinical manifestations and prognosis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Westmead Hospital, Westmead, New South Wales, Australia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 7
Outcome is the decay rate in viral load during hospital stay measured by quantitative polymerase chain reaction (QPCR)
Time frame: Day 9
Outcome is the decay rate in viral load during hospital stay measured by quantitative polymerase chain reaction (QPCR)
Time frame: Day 11
Outcome is the decay rate in viral load during hospital stay measured by quantitative polymerase chain reaction (QPCR)
Time frame: Day 13
Outcome is the decay rate in viral load during hospital stay measured by quantitative polymerase chain reaction (QPCR)
Time frame: Day 15
Outcome is the decay rate in viral load during hospital stay measured by quantitative polymerase chain reaction (QPCR)
Crucell Holland BV
Industry
Prospective Study to Evaluate Viral Shedding Patterns and Clinical Outcomes of Hospitalized Adult Influenza Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05968989
Infections, Influenza
Bethesda, Maryland, United States
View Trial DetailsNCT05827926
Coronaviridae Infections, Coronavirus Infections
Chandler, Arizona, United States
View Trial DetailsNCT05972174
Infections, Influenza
Hollywood, Florida, United States
View Trial DetailsNCT06161454
Coronaviridae Infections, Coronavirus Infections
Philadelphia, Pennsylvania, United States
View Trial Details